Skip to main content

Table 2 Cardiac measures

From: High output cardiac failure in 3 patients with hereditary hemorrhagic telangiectasia and hepatic vascular malformations, evaluation of treatment

 

Patient 1

Patient 2

Patient 3

Before

After OLT

Before

After BVZ

Before

After BVZ

NYHA-class

II

I

II

I

III

I

AF

Yesa

Yesa

No

No

Yes

Yes

Peripheral edema

Yes

No

Yes

Reduced

Yes

Reduced

  1. aParoxysmal
  2. OLT orthotopic liver transplantation, BVZ bevacizumab, NYHA New York Heart Association, AF atrial fibrillation
Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172